title: Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background.
abstract: Pathway analysis of genome-wide association studies (GWAS) offer a unique opportunity to collectively evaluate genetic variants with effects that are too small to be detected individually. We applied a pathway analysis to a bladder cancer GWAS containing data from 3,532 cases and 5,120 controls of European background (n = 5 studies). Thirteen hundred and ninety-nine pathways were drawn from five publicly available resources (Biocarta, Kegg, NCI-PID, HumanCyc, and Reactome), and we constructed 22 additional candidate pathways previously hypothesized to be related to bladder cancer. In total, 1421 pathways, 5647 genes and ∼90,000 SNPs were included in our study. Logistic regression model adjusting for age, sex, study, DNA source, and smoking status was used to assess the marginal trend effect of SNPs on bladder cancer risk. Two complementary pathway-based methods (gene-set enrichment analysis [GSEA], and adapted rank-truncated product [ARTP]) were used to assess the enrichment of association signals within each pathway. Eighteen pathways were detected by either GSEA or ARTP at P≤0.01. To minimize false positives, we used the I(2) statistic to identify SNPs displaying heterogeneous effects across the five studies. After removing these SNPs, seven pathways ('Aromatic amine metabolism' [P(GSEA) = 0.0100, P(ARTP) = 0.0020], 'NAD biosynthesis' [P(GSEA) = 0.0018, P(ARTP) = 0.0086], 'NAD salvage' [P(ARTP) = 0.0068], 'Clathrin derived vesicle budding' [P(ARTP) = 0.0018], 'Lysosome vesicle biogenesis' [P(GSEA) = 0.0023, P(ARTP)<0.00012], 'Retrograde neurotrophin signaling' [P(GSEA) = 0.00840], and 'Mitotic metaphase/anaphase transition' [P(GSEA) = 0.0040]) remained. These pathways seem to belong to three fundamental cellular processes (metabolic detoxification, mitosis, and clathrin-mediated vesicles). Identification of the aromatic amine metabolism pathway provides support for the ability of this approach to identify pathways with established relevance to bladder carcinogenesis.
authors.affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. menashei@mail.nih.gov
authors.forename: Idan
authors.initials: I
authors.lastname: Menashe
authors.forename: Jonine D
authors.initials: JD
authors.lastname: Figueroa
authors.forename: Montserrat
authors.initials: M
authors.lastname: Garcia-Closas
authors.forename: Nilanjan
authors.initials: N
authors.lastname: Chatterjee
authors.forename: Nuria
authors.initials: N
authors.lastname: Malats
authors.forename: Antoni
authors.initials: A
authors.lastname: Picornell
authors.forename: Dennis
authors.initials: D
authors.lastname: Maeder
authors.forename: Qi
authors.initials: Q
authors.lastname: Yang
authors.forename: Ludmila
authors.initials: L
authors.lastname: Prokunina-Olsson
authors.forename: Zhaoming
authors.initials: Z
authors.lastname: Wang
authors.forename: Francisco X
authors.initials: FX
authors.lastname: Real
authors.forename: Kevin B
authors.initials: KB
authors.lastname: Jacobs
authors.forename: Dalsu
authors.initials: D
authors.lastname: Baris
authors.forename: Michael
authors.initials: M
authors.lastname: Thun
authors.forename: Demetrius
authors.initials: D
authors.lastname: Albanes
authors.forename: Mark P
authors.initials: MP
authors.lastname: Purdue
authors.forename: Manolis
authors.initials: M
authors.lastname: Kogevinas
authors.forename: Amy
authors.initials: A
authors.lastname: Hutchinson
authors.forename: Yi-Ping
authors.initials: YP
authors.lastname: Fu
authors.forename: Wei
authors.initials: W
authors.lastname: Tang
authors.forename: Laurie
authors.initials: L
authors.lastname: Burdette
authors.forename: Adonina
authors.initials: A
authors.lastname: Tardón
authors.forename: Consol
authors.initials: C
authors.lastname: Serra
authors.forename: Alfredo
authors.initials: A
authors.lastname: Carrato
authors.forename: Reina
authors.initials: R
authors.lastname: García-Closas
authors.forename: Josep
authors.initials: J
authors.lastname: Lloreta
authors.forename: Alison
authors.initials: A
authors.lastname: Johnson
authors.forename: Molly
authors.initials: M
authors.lastname: Schwenn
authors.forename: Alan
authors.initials: A
authors.lastname: Schned
authors.forename: Gerald
authors.initials: G
authors.lastname: Andriole
authors.forename: Amanda
authors.initials: A
authors.lastname: Black
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Jacobs
authors.forename: Ryan W
authors.initials: RW
authors.lastname: Diver
authors.forename: Susan M
authors.initials: SM
authors.lastname: Gapstur
authors.forename: Stephanie J
authors.initials: SJ
authors.lastname: Weinstein
authors.forename: Jarmo
authors.initials: J
authors.lastname: Virtamo
authors.forename: Neil E
authors.initials: NE
authors.lastname: Caporaso
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Landi
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Fraumeni
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Chanock
authors.forename: Debra T
authors.initials: DT
authors.lastname: Silverman
authors.forename: Nathaniel
authors.initials: N
authors.lastname: Rothman
mesh_terms: D033942:Adaptor Proteins, Vesicular Transport / Q000235:genetics; D002277:Carcinoma / Q000235:genetics*; D016022:Case-Control Studies; D015331:Cohort Studies; D005060:Europe; D005260:Female; D018816:Genes, cdc; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D008938:Mitosis / Q000235:genetics; D015398:Signal Transduction / Q000235:genetics; D001749:Urinary Bladder Neoplasms / Q000235:genetics*
chemical_list: D033942:Adaptor Proteins, Vesicular Transport